• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多黏菌素E甲磺酸钠在腹膜透析真菌性腹膜炎治疗中的应用失败。

Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.

作者信息

Gallieni M, Chiarelli G, Olivi L, Cozzolino M, Cusi D

机构信息

Dipartimento Medicina Chirurgia Odontoiatria, Università degli Studi di Milano, Italy.

出版信息

Clin Nephrol. 2011 Jan;75(1):70-3.

PMID:21176753
Abstract

Fungal peritonitis (FP) is a serious complication for peritoneal dialysis (PD) patients, determining hospitalization, technique failure, catheter loss and death. In the 2005 update, treatment recommendations for FP from the International Society of Peritoneal Dialysis (ISPD) advocate catheter removal immediately after fungi are identified by microscopy or culture. The availability of more effective medical treatments could therefore be of great importance. The aim of this report is to describe a case of a 43-year-old, diabetic, HIV positive PD patient with fluconazole resistant Candida peritonitis, who was treated with an i.p. taurolidine solution. Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties. It has been used during surgery for lavage of the peritoneum in cases of peritonitis. Its mechanism of action is related to direct toxic action on micro-organisms, through a chemical reaction between active taurolidine derivatives and structures on the cell wall. Treatment failed because the patient had severe burning pain during i.p. administration of the drug, limiting its dose. PD catheter removal allowed complete recovery. It remains undetermined if, with different doses and methodology, taurolidine could be more effective in treating bacterial and/or fungal peritonitis. Currently, catheter removal remains the most effective therapy of fungal peritonitis.

摘要

真菌性腹膜炎(FP)是腹膜透析(PD)患者的一种严重并发症,可导致住院、技术失败、导管拔除及死亡。在2005年的更新版中,国际腹膜透析学会(ISPD)对FP的治疗建议主张在通过显微镜检查或培养鉴定出真菌后立即拔除导管。因此,获得更有效的药物治疗可能非常重要。本报告的目的是描述一例43岁、患有糖尿病、HIV阳性的PD患者,其患有对氟康唑耐药的念珠菌性腹膜炎,接受了腹腔内牛磺罗定溶液治疗。牛磺罗定是一种非抗生素类抗菌剂,具有广泛的杀菌和杀真菌特性。它已在腹膜炎病例的手术中用于冲洗腹膜。其作用机制与活性牛磺罗定衍生物与细胞壁结构之间的化学反应对微生物的直接毒性作用有关。治疗失败是因为患者在腹腔内给药期间出现严重灼痛,限制了药物剂量。拔除PD导管后患者完全康复。目前尚不确定采用不同剂量和方法时,牛磺罗定在治疗细菌性和/或真菌性腹膜炎方面是否会更有效。目前,拔除导管仍然是真菌性腹膜炎最有效的治疗方法。

相似文献

1
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.多黏菌素E甲磺酸钠在腹膜透析真菌性腹膜炎治疗中的应用失败。
Clin Nephrol. 2011 Jan;75(1):70-3.
2
Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter.氟康唑治疗念珠菌性腹膜炎并延迟拔除腹膜透析导管
Clin Nephrol. 1995 Jul;44(1):60-3.
3
Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.持续性非卧床腹膜透析患者的非白色念珠菌真菌性腹膜炎
Adv Perit Dial. 2001;17:176-9.
4
Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.复发性腹膜炎与牛磺罗定腹腔导管封管:单中心经验。
J Vasc Access. 2021 Mar;22(2):261-265. doi: 10.1177/1129729820937099. Epub 2020 Jun 30.
5
Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.牛磺罗定作为腹膜透析患者复发性腹膜炎的辅助治疗。
Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):197-201. doi: 10.1016/j.nefro.2019.03.014. Epub 2019 Jun 15.
6
Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.长期腹膜透析经验:质量控制支持使用氟康唑预防真菌性腹膜炎。
Int J Artif Organs. 2013 Jul;36(7):484-8. doi: 10.5301/ijao.5000219. Epub 2013 May 10.
7
Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.真菌性腹膜炎在腹膜透析患者中的预防:氟康唑的前瞻性随机对照试验证实其有效。
Perit Dial Int. 2010 Nov-Dec;30(6):619-25. doi: 10.3747/pdi.2008.00189. Epub 2010 Jul 15.
8
Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar.卡塔尔腹膜透析相关性腹膜炎的微生物谱及结局
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):168-73.
9
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].[重新插入腹膜导管后念珠菌引起的复发性腹膜炎]
Nefrologia. 2009;29(2):183. doi: 10.3265/Nefrologia.2009.29.2.4886.en.full.
10
Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.腹腔内尿激酶在急性腹膜炎及腹膜透析患者预防导管丢失中的作用
Adv Perit Dial. 2000;16:233-6.

引用本文的文献

1
Peritoneal dialysis associated infections: An update on diagnosis and management.腹膜透析相关感染:诊断与管理的最新进展
World J Nephrol. 2012 Aug 6;1(4):106-22. doi: 10.5527/wjn.v1.i4.106.
2
Peritoneal dialysis-related infections recommendations: 2010 update. What is new?腹膜透析相关性感染治疗推荐:2010 年更新。有哪些新内容?
Int Urol Nephrol. 2012 Apr;44(2):593-600. doi: 10.1007/s11255-011-9995-9. Epub 2011 Jul 9.